Stryker Corporation
SYKStryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.
- Revenue
- +7.64%
- EPS
- −11.8%
- Free cash flow
- −19.4%
- Total debt
- −10.0%
Quarter to September 2026, against a year earlier
Follow SYK
Alert me
Stryker Corporation (SYK) P/E ratio
As of 13 November 2026, Stryker Corporation (SYK) trades at a P/E ratio of 32.7×. Over the past ten years it has ranged from 16.1× (January 2019) to 71.2× (April 2021); the current reading is higher than 31% of that period. That is above the Medical Devices industry median of 25.0× and above the Healthcare sector median of 25.3×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 41.4× | (9.74%) |
| FY2024 | 45.9× | 29.13% |
| FY2023 | 35.5× | (10.06%) |
| FY2022 | 39.5× | (21.88%) |
| FY2021 | 50.6× | (11.91%) |
| FY2020 | 57.4× | 52.25% |
| FY2019 | 37.7× | 128.19% |
| FY2018 | 16.5× | (71.44%) |
| FY2017 | 57.8× | 113.57% |
| FY2016 | 27.1× | 11.31% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 29.1× | (9.94%) |
| Jun 2026 | 32.4× | (14.03%) |
| Mar 2026 | 37.6× | (9.08%) |
| Dec 2025 | 41.4× | (13.66%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | 17.4× |
| BSX Boston Scientific Corporation compare | 18.7× |
| MDT Medtronic PLC compare | 25.2× |
| PHG Koninklijke Philips N.V. compare | 25.6× |
| STE STERIS plc compare | 31.2× |
| DXCM DexCom, Inc. compare | 32.2× |
| SYK Stryker Corporation | 32.7× |
| ABT Abbott Laboratories compare | 40.4× |
| EW Edwards Lifesciences Corporation compare | 60.5× |
| Medical Devices industry median | 25.0× |
| Healthcare sector median | 25.3× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on SYK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement